Tag: <span>Alzheimer’s disease</span>

Home / Alzheimer’s disease
Optimal blood tests for development of new therapies of Alzheimer’s disease
Post

Optimal blood tests for development of new therapies of Alzheimer’s disease

UNIVERSITY OF GOTHENBURG IMAGE: NICHOLAS ASHTON, KAJ BLENNOW AND OSKAR HANSSON. CREDIT: PHOTO: UNIVERSITY OF GOTHENBURG, LUND UNIVERSITY. A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new...

Deteriorating neurons are source of human brain inflammation in Alzheimer’s disease
Post

Deteriorating neurons are source of human brain inflammation in Alzheimer’s disease

by Salk Institute Neurons (green) derived from a patient with Alzheimer’s disease. The nuclei (blue) of the neurons are also shown. Credit: Salk Institute Despite decades of research, Alzheimer’s disease remains a debilitating and eventually fatal dementia with no effective treatment options. More than 95 percent of Alzheimer’s disease cases have no known origin. Now,...

Researchers study relationship between epilepsy drug and Alzheimer’s disease
Post

Researchers study relationship between epilepsy drug and Alzheimer’s disease

by Indiana University School of Medicine Pharmacokinetic analysis of levetiracetam (LEV) in 6-month aged 5XFAD mice reveals significant sex differences. A, Plasma concentration time profiles of LEV by dose and sex in 5XFAD males and females. B, One-compartment model fit for the 30 mg/kg dose. C, Volume of distribution (V/F) and clearance (CL/F) is shown....

The brain’s immune cells can be triggered to slow down Alzheimer’s disease, study shows
Post

The brain’s immune cells can be triggered to slow down Alzheimer’s disease, study shows

by Lund University Visual representation of the role of microglia activation in longitudinal accumulation of amyloid and tau aggregates. When microglia are in a homeostatic state, they do not protect against the accumulation of amyloid and tau aggregates, which increase over time in individuals at risk of developing Alzheimer’s disease (AD) (a). In contrast, when...

Biomarker in urine could be the first to reveal early-stage Alzheimer’s disease
Post

Biomarker in urine could be the first to reveal early-stage Alzheimer’s disease

by Frontiers Credit: Unsplash/CC0 Public Domain Alzheimer’s disease can remain undetected until it is too late to treat. Large-scale screening programs could help to detect early-stage disease, but current diagnostic methods are too cumbersome and expensive. Now, a new study is the first to identify formic acid as a sensitive urinary biomarker that can reveal...

Researchers identify protein that contributes to tau neurotoxicity in Alzheimer’s disease
Post

Researchers identify protein that contributes to tau neurotoxicity in Alzheimer’s disease

by Indiana University School of Medicine A high-molecular-weight tau seed interacts with BSN protein. a, Schematic of the tau-seeding assay of SEC fractions. b, Tau-seeding activity of SEC fractions obtained from 3-month-old PS19 and WT mouse brain lysates. c, Total human tau (hTau) detected by ELISA in SEC fractions from PS19 and WT mouse brain lysates. d, Tau-seeding activity...